The Latest Breaking News from Pfizer

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

Incidence of serious sexually transmitted disease at 27-year high and demand for preferred antibiotic is straining manufacture

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

PFE is a beaten-down healthcare stock that trades at a discount to consensus price target estimates. Is Pfizer stock a good buy right now?

Should the government do more to support people with long-COVID?

Thin characterisation and a slightly preachy message hold this 90-minute film back, but its heart is in the right place

As Pfizer (PFE) navigates a post-pandemic world with a shifting focus away from COVID-related products, what should investors expect from this pharma giant? Let’s look at its financial metrics to know more….